Evidence map›Paper›PMID 37953772›Full record

ArticlePeerJ2023

RBM25 binds to and regulates alternative splicing levels of

Xin Tian, Guangli Zhou, Hao Li, Xueting Zhang, Lingmin Zhao, Keyi Zhang, Luqiao Wang, Mingwei Liu, Chen Liu, Ping Yang

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Xin TianDepartment of Cardiology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Guangli ZhouDepartment of Cardiology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Hao LiDepartment of Cardiology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Xueting ZhangDepartment of Cardiology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Lingmin ZhaoDepartment of Cardiology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Keyi ZhangDepartment of Cardiology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Luqiao WangDepartment of Cardiology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Mingwei LiuDepartment of Cardiology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Chen LiuDepartment of Radiology, Affiliated Hospital of Yunnan University, Kunming, China.
Ping YangDepartment of Cardiology, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
Kunming Medical University · CNYunnan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Alternative splicing (AS) is a biological process that allows genes to be translated into diverse proteins. However, aberrant AS can predispose cells to aberrations in biological mechanisms. RNA binding proteins (RBPs), closely affiliated with AS, have gained increased attention in recent years. Among these RBPs, RBM25 has been reported to participate in the cardiac pathological mechanism through regulating AS; however, the involvement of RBM25 as a splicing factor in heart failure remains unclarified. Methods: RBM25 was overexpressed in H9c2 cells to explore the target genes bound and regulated by RBM25 during heart failure. RNA sequencing (RNA-seq) was used to scrutinize the comprehensive transcriptional level before identifying AS events influenced by RBM25. Further, improved RNA immunoprecipitation sequencing (iRIP-seq) was employed to pinpoint RBM25-binding sites, and RT-qPCR was used to validate specific genes modulated by RBM25. Results: RBM25 was found to upregulate the expression of genes pertinent to the inflammatory response and viral processes, as well as to mediate the AS of genes associated with cellular apoptosis and inflammation. Overlap analysis between RNA-seq and iRIP-seq suggested that RBM25 bound to and manipulated the AS of genes associated with inflammation in H9c2 cells. Moreover, qRT-PCR confirmed Conclusion: Our research implies that RBM25 plays a contributory role in cardiac inflammatory responses via its ability to bind to and regulate the AS of related genes. This study offers preliminary evidence of the influence of RBM25 on inflammation in H9c2 cells.

Indexed as

Alternative SplicingHeart FailureRNA Recognition Motif ProteinsRNA Splicing FactorsAnimalsInflammationNuclear ProteinsRatsRNA-Binding ProteinsNuclear ProteinsRNA-Binding ProteinsRNA Recognition Motif ProteinsRNA Splicing FactorsAlternative splicingH9c2 cellHeart failureImproved RNA immunoprecipitation sequencingInflammationRBM25RNA-seq

Identifiers

PMID37953772
PMCPMC10637245
OpenAlexW4388462598

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.